Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

There was a post on Livimmune reddit discussing a

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 158026
(Total Views: 291)
Posted On: 10/17/2025 9:21:26 PM
Posted By: twinter11
Re: Katangolo #158022
There was a post on Livimmune reddit discussing a recent conf
Here
https://www.reddit.com/r/Livimmune/comments/1...about_hiv/

..." Dr. Sacha was at the 42nd Annual Nonhuman Primate AIDS Symposium Sept 30th to Oct 3rd and chaired a session on next-gen delivery systems.

He gave a talk on using AAV vectors to deliver a “CCR5 blocking antibody.” Anybody know of any CCR5 antibodies? He also oversaw talks on long-acting antibodies, pediatric AAV delivery, and CAR-T approaches.

It appears Drs. Helen Wu and Gabriela Webb from OHSU were there too, they’ve co authored papers with Sacha on leronlimab"...

About this conf.
https://conferences.union.wisc.edu/primate/pr...ce-agenda/

A reply from BGS stated:
That program looks like 3 separate presentations about leronlimab with people from OHSU.

"AAV delivery of antibody-mediated CCR5 blockade for HIV treatment", Jonah Sacha

"AAV-delivery of anti-CCR5 blocking antibody for pediatric HIV prevention", Gabriela Webb

"Ultra-high concentration microparticle formulation of LS-variant anti-CCR5 monoclonal antibody provides protection against intrarectal SHIV acquisition in rhesus macaques", Helen Wu"

I looked up the 2nd presentation but it appeared it might have been from an already published abstract. Not positive though

A search for the title of the 3rd presentation brought up the poster. And that was really the one I was looking for due to the Long Acting Leronlimab implications.

I didnt search for the first presentation mentioned.
There are a couple additional links etc. in the original post at Livimmune link
Thanks!



(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us